Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Molecular Analysis for Precision Oncology Congress 2024

ESMO-MAP-2024-1000x250-Molecular-Analysis

Start date: 16 Oct 2024
End date: 18 Oct 2024
Location: London, United Kingdom

The Molecular Analysis for Precision Oncology Congress 2024 will take place on 16-18 October 2024 in London, UK.

MAP focuses on current and emerging approaches in precision oncology, highlights successes and challenges, and proposes potential solutions in clinical research and practice.

This event constitutes an excellent occasion to reunite basic scientists, people working on new technologies, medical doctors, and healthcare providers.

Our globally recognised experts in the field await you for three days of discussions on discoveries in precision medicine, technologies for cancer profiling, mechanisms driving tumour expansion, metastatic dissemination, clonal evolution, and biomarker-driven development of targeted therapeutics.

After the success of the first edition in 2023, this year RoadMAP to the Clinic will focus on “The use of AI for drug development/precision medicine”. This special day during MAP will feature lectures and panel discussions involving investigators, regulatory and methodological experts, industry and patient representatives on the burning topics of deploying AI at scale, tackling regulatory and ethical aspects of AI implementation in clinical trials and examining the opportunities and challenges of AI for research and practice.

The MAP Congress is the result of a solid partnership among Cancer Research UK (CRUK), the European Society for Medical Oncology (ESMO) and Unicancer, all committed to offering the best care to people with cancer worldwide, through oncology education and research.